receives

BioDlink Commends Junshi Biosciences as its Bispecific ADC Candidate JS212 Receives IND Approval

News Medical September 12, 2025 0Comment

BioDlink, a leading global CDMO, extends its congratulations to Junshi Biosciences, on receiving Investigational New Drug (IND) approval

Health Psychology

Narcissism shows surprisingly consistent patterns across 53 countries, study finds

This Chinese Startup Wants to Build a New Brain-Computer Interface—No Implant Required

Nitrate source matters more than nitrate amount

This Brain Condition Quadruples Dementia Risk And Most People Have Never Heard of It